Literature DB >> 21029252

Transient hyperphosphatasemia in children revisited.

Neta Dori1, Lily Levi, Tamar Stam, Igor Sukhotnik, Ron Shaoul.   

Abstract

OBJECTIVE: Although transient hyperphosphatasemia (TH) has been well known for decades, its etiology and pathophysiology remain unclear. We aimed to study the clinical characteristics of children diagnosed with TH compared to older studies in order to expand our knowledge and understanding of this condition and to try and find a subgroup of children who are more prone to develop TH.
METHODS: We retrospectively studied 60 children diagnosed at Maccabi Health Services and Bnai Zion Medical Center, Haifa, Israel with TH between the years 2003-08. One hundred and twenty-two children matched by age, gender and presenting symptoms served as the control group. The patients were divided into four subgroups by their presenting symptoms: infectious disease 33%, failure to thrive 28%, diarrhea 15% and other 23%. The Hydragel 7 ISO-PAL and Hydragel 15 ISO-PAL kits were used for the identification and quantification of ALP isoenzymes in human serum.
RESULTS: The ALP levels of the study group were 805-8619 U\L (mean 2311 U\L), without differences between the subgroups. The mean duration of TH was 12 weeks. ALP isoenzymes levels were measured in one-third of the patients, and showed that the bone isoenzyme was elevated in most. Forty-three (71%) subjects were diagnosed in the second half of the calendar year.
CONCLUSIONS: We could not establish an etiological explanation for TH. We presume that it is a complex mechanism in which different stimuli led to upregulation of the enzyme.
© 2010 The Authors. Pediatrics International © 2010 Japan Pediatric Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029252     DOI: 10.1111/j.1442-200X.2010.03265.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

1.  Transient hyperphosphatasemia in children.

Authors:  Rolan Bassrawi; Narjes Alsabie; Deema Alsorani; Amir Babiker
Journal:  Sudan J Paediatr       Date:  2014

2.  Benign transient hyperphosphatasemia in an infant during zinc supplementation.

Authors:  Ayça Bilge Sönmez; İlter Arifoğlu; Ahmet Yıldırım; Filiz Tütüncüler
Journal:  Turk Pediatri Ars       Date:  2018-06-01

3.  Normal bone turnover in transient hyperphosphatasemia.

Authors:  Stepan Kutilek; Barbora Cervickova; Pavla Bebova; Marie Kmonickova; Vladimir Nemec
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-05-03

4.  A case series of benign transient hyperphosphatasemia from a pediatric endocrinology reference health facility in Turkey.

Authors:  Fatma Dursun; Heves Kirmizibekmez
Journal:  Pan Afr Med J       Date:  2018-07-11

5.  Brazilian guidelines for chronic kidney disease-mineral and bone metabolism disorders in children and adolescents.

Authors:  Ana Lúcia Cardoso Santos Abreu; Emília Maria Dantas Soeiro; Leonardo Gonçalves Bedram; Maria Cristina de Andrade; Renata Lopes
Journal:  J Bras Nefrol       Date:  2021-12-03

6.  Transient hyperphosphatasemia: Possible association with pediatric acute respiratory infection.

Authors:  Yoshihiko Sakurai; Takafumi Higashiguchi
Journal:  Pediatr Investig       Date:  2021-06-18

7.  Hepatitis during respiratory syncytial virus infection--a case report.

Authors:  Branka Kristić Kirin; Renata Zrinski Topić; Slavica Dodig
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

8.  Do all infants need vitamin D supplementation?

Authors:  Ane Cristina Fayão Almeida; Francisco José Albuquerque de Paula; Jacqueline Pontes Monteiro; Carlos Alberto Nogueira-de-Almeida; Luiz Antonio Del Ciampo; Davi Casale Aragon; Ivan Savioli Ferraz
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.